BACK TO FUND'S DETAIL PAGE
All Holdings
All Holdings
1977 Total Holdings:
As of 6/30/24
All Holdings:
1 -
15 of
1977
| Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets 
|
|---|---|---|---|---|
| Broadcom, Inc. | Equity | 2,771,899 | $4,450,367,001.00 | 4.3% |
| Capital Group Central Cash Fund | Short Term | 34,530,591 | $3,453,059,112.00 | 3.34% |
| Capital Group Central Corporate Bond Fund | Investment Fund | 301,035,526 | $2,489,563,797.00 | 2.4% |
| Philip Morris International, Inc. | Equity | 24,408,173 | $2,473,280,170.00 | 2.39% |
| Microsoft Corp. | Equity | 5,332,283 | $2,383,263,887.00 | 2.3% |
| AbbVie, Inc. | Equity | 13,628,349 | $2,337,534,420.00 | 2.26% |
| RTX Corp. | Equity | 18,699,296 | $1,877,222,325.00 | 1.81% |
| Taiwan Semiconductor Manufacturing Co., Ltd. | Equity | 52,143,856 | $1,550,836,946.00 | 1.5% |
| VICI Properties, Inc. REIT | Equity | 49,410,330 | $1,415,111,851.00 | 1.37% |
| JPMorgan Chase & Co. | Equity | 6,847,397 | $1,384,954,517.00 | 1.34% |
| Abbott Laboratories | Equity | 11,893,783 | $1,235,882,992.00 | 1.19% |
| AstraZeneca PLC | Equity | 7,409,377 | $1,155,092,642.00 | 1.12% |
| Canadian Natural Resources, Ltd. | Equity | 31,445,002 | $1,120,072,327.00 | 1.08% |
| Amgen, Inc. | Equity | 3,457,394 | $1,080,262,755.00 | 1.04% |
| Gilead Sciences, Inc. | Equity | 15,716,407 | $1,078,302,684.00 | 1.04% |
All Holdings:
1 -
15 of
1977